Olanzapine affects locomotor activity and meal size in male rats

被引:39
作者
van der Zwaal, Esther M. [2 ]
Luijendijk, Mieneke C. M. [2 ]
Evers, Simon S. [3 ]
la Fleur, Susanne E. [1 ,2 ]
Adan, Roger A. H. [2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, NL-3584 GC Utrecht, Netherlands
[3] Univ Groningen, Dept Neuroendocrinol, NL-9751 NN Haren, Netherlands
关键词
Olanzapine; Adiposity; Locomotor activity; Meal size; Food preference; Rat;
D O I
10.1016/j.pbb.2010.05.009
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Olanzapine is an antipsychotic drug that frequently induces weight gain accompanied by increased fat deposition as a side effect To investigate how olanzapine affects different aspects of energy balance we used male rats to determine effects on meal patterns food preference locomotor activity and body temperature In two short-term experiments olanzapine was administered via osmotic minipumps In the first experiment we offered rats standard lab chow only In the second experiment we offered rats free choice between chow sucrose and saturated fat In a third experiment olanzapine was chronically administered via the drinking water to determine effects on body composition In each experiment olanzapine decreased locomotor activity and altered meal patterns Olanzapine caused an increase in average meal size accompanied by reduced meal frequency without clearly affecting food preference In the chronic experiment body composition was altered favoring adipose tissue over lean muscle mass despite reductions in overall body weight gain The increase in average meal size implies that the primary effect of olanzapine on feeding is an impairment of the normal satiation process Furthermore energy balance is clearly affected by a reduction in locomotor activity Thus the effects of olanzapine on adiposity do not depend solely on the presence of hyperphagra (C) 2010 Elsevier Inc All nghts reserved
引用
收藏
页码:130 / 137
页数:8
相关论文
共 68 条
  • [1] ALBAUGH H, 2006, OBESITY SILVER SPRIN, V14, P36
  • [2] Aravagiri M, 1999, BIOPHARM DRUG DISPOS, V20, P369, DOI 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO
  • [3] 2-6
  • [4] An animal model of antipsychotic-induced weight gain
    Arjona, AA
    Zhang, SX
    Adamson, B
    Wurtman, RJ
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2004, 152 (01) : 121 - 127
  • [5] Olanzapine-associated hypothermia
    Blass, DM
    Chuen, M
    [J]. PSYCHOSOMATICS, 2004, 45 (02) : 135 - 139
  • [6] OVARIAN INFLUENCES ON MEAL PATTERNS OF FEMALE RATS
    BLAUSTEIN, JD
    WADE, GN
    [J]. PHYSIOLOGY & BEHAVIOR, 1976, 17 (02) : 201 - 208
  • [8] BLOUIN T, 2008, OBESITY SILVER SPRIN, V16, P1780
  • [9] Serum leptin levels increase rapidly after initiation of clozapine therapy
    Bromel, T
    Blum, WF
    Ziegler, A
    Schulz, E
    Bender, M
    Fleischhaker, C
    Remschmidt, H
    Krieg, JC
    Hebebrand, J
    [J]. MOLECULAR PSYCHIATRY, 1998, 3 (01) : 76 - 80
  • [10] CALLAGHAN B, 1999, PHARM, V37, P177